Tag:
Intellipharmaceutics
Latest Headlines
Latest Headlines
Intellipharmaceutics raises $5M to adance tamper-resistant oxycodone
Canada's Intellipharmaceutics International ($IPCI), a specialist in controlled-release drug formulations, is raising $5 million to fuel anticipated U.S. clinical trials for Rexista, a patented version of the highly addictive pain killer oxycodone designed to resist abuse.
Intellipharmaceutics aims for abuse-deterrent painkiller
Intellipharmaceutics is currently using new and customized equipment to manufacture clinical batches of drugs aiming to deter abuse. The company says it has completed qualification of the primary
